Hearing Function After Intratympanic Application of Gadolinium- Based Contrast Agent: A Long-term Evaluation
|
|
- Archibald Summers
- 5 years ago
- Views:
Transcription
1 The Laryngoscope VC 2015 The American Laryngological, Rhinological and Otological Society, Inc. Hearing Function After Intratympanic Application of Gadolinium- Based Contrast Agent: A Long-term Evaluation Julia Louza, MD; Eike Krause, MD; Robert G urkov, MD Objectives/Hypothesis: The aim of this study was to evaluate the long-term influence of intratympanic gadoliniumbased contrast agent on hearing function in patients with possible Menière s disease and normal auditory thresholds who were undergoing locally enhanced magnetic resonance imaging scans. Study Design: Prospective observational cohort study in a tertiary referral university hospital ear, nose, and throat department. Methods: Between 2009 and 2012, 17 patients with possible or probable Menière s disease and a four-tone pure-tone average baseline of <25 db were recruited for our study. Before undergoing intratympanic injection of gadolinium-based contrast agent, all patients underwent a complete audiological evaluation. The study population was then invited back after at least 6 months postinjection for a follow-up auditory evaluation. This consisted of comprehensive clinical and audiological tests on both sides and were evaluated according to the ototoxicity guidelines. Results: A long-term evaluation of our study group revealed no significant difference in the air-conduction pure-tone average. Furthermore, no statistical difference at individual frequencies compared to baseline was found. There was no evidence of ototoxicity in the injected ear. Conclusions: Long-term hearing function assessment after intratympanic application of gadolinium-based agent showed no evidence of ototoxicity. The use of intratympanic gadolinium-based agent in the diagnosis of Menières disease is currently a helpful tool, and seems to be a safe method, especially with regard to auditory function. Key Words: Gadolinium, intratympanic application, hearing function, Menière s disease, long term. Level of Evidence: 4. Laryngoscope, 125: , 2015 INTRODUCTION Until recently, Menière s disease, the idiopathic syndrome of endolymphatic hydrops (ELH), was diagnosed based only on its clinical presentation: aural fullness and/or hearing loss, tinnitus, and recurrent vertigo attacks. The confirmation of the diagnosis was only possible in postmortem investigation. Newer technologies, including magnetic resonance imaging (MRI) and the use of intratympanic gadoliniumbased contrast agent (GBCA), have opened a new era in the diagnosis of ELH and Menière s disease. 1 3 These techniques are particularly important for the differential diagnosis of diseases with similar symptoms, (e.g., vestibular migraine). 4,5 The intravenous use of GBCA in MRI is a very safe method and has been used for more than 20 years. Contraindications are very few: chronic severe kidney disease, acute kidney injury, or history of hypersensibility From the Department of Otorhinolaryngology Head and Neck Surgery, Ludwig-Maximilians University of Munich, Munich, Germany Editor s Note: This Manuscript was accepted for publication February 17, The authors have no funding, financial relationships, or conflicts of interest to disclose. Send correspondence to Julia Louza, MD, Department of Otorhinolaryngology Head and Neck Surgery, Ludwig-Maximilians University of Munich, Marchioninistrasse 15, Munich, Germany. julia. louza@med.uni-muenchen.de DOI: /lary reactions to other GBCAs. Patients with this medical history should avoid GBCA because of the increased risk of nephrogenic systemic fibrosis. 6 Less severe complications include headache, dizziness, and nausea. 7 The intratympanic route of application of GBCA uses the round window transport capacity to access the perilymph system and thus bypasses the cardiovascular system. The result is a stronger signal intensity of relevant structures compared to the intravenous route. 1 The increasing utilization of MRI with intratympanic GBCA injection to evaluate inner ear pathology has raised concerns about the possible side effects of this substance on the function of the inner ear. Experimental studies with animal models have shown that eightfold diluted GBCA did not have any apparent effects on the stria vascularis of guinea pigs. 8 Aprevious clinical study with 21 Menière s disease patients has shown that the intratympanic use of GBCA had no adverse effects on audiological function 1 day after application. 9 Another follow-up study evaluated the hearing function not only directly after application but also 1 week later. The results of this study with 65 patients having possible Menière s disease showed no hearing deterioration. 10 However, the long-term influence of GBCA on hearing function is still unknown. The aim of this study was to evaluate the long-term effects of GBCA on hearing function in patients with normal auditory thresholds.
2 TABLE I. Time After MRI. Time After MRI (mo) No. 17 Mean 20 Median 20 SD 8 Minimum 7 Maximum 34 MRI 5 magnetic resonance imaging; SD 5 standard deviation. MATERIALS AND METHODS Patients Inclusion criteria were possible or probable Menière s disease, 11 age more than 18 years, and a four-tone pure-tone average (PTA) baseline of <25 db, as well as a speech recognition score at 60 db of at least 85%. Therefore, the study population consisted of patients with largely preserved hearing function. Exclusion criteria were previous otologic surgery, ablative therapy (e.g., gentamicin), presence of ventilation tube, and/or any kind of middle ear disease. Contrast-enhanced T1-weighted MRI was used to rule out vestibular schwannoma. The study was performed in a large tertiary referral neurotology center of a university hospital. The study protocol was approved by the local institutional review board, and patients gave their written informed consent. Between 2009 and 2012, 17 consecutive patients (7 male and 10 female) were included. Four patients were injected on the right side and 13 patients on the left side. The side of injection was chosen according to the laterality of aural symptoms as reported by the patients. The average age at the time of MRI was 41 years (range, years). For evaluation of short-term effects, all patients underwent clinical and audiological testing immediately before and 1 day after injection. At least 6 months after MRI, the study population was invited to have a follow-up evaluation, which again included clinical and audiological tests (in both ears at this time). All hearing thresholds were additionally evaluated according to the American Speech-Language- Hearing Association s ototoxicity guidelines. 12 is regularly recalibrated (every 6 months) according to the local university equipment standard. Data Analysis Patient data were stored and analyzed with SPSS software (IBM SPSS Statistics version 22; IBM, Armonk, NY). The analysis included descriptive statistics and Wilcoxon signed rank tests at the P 5.05 level. For comparison of injected side and noninjected side, PTA and McNemar s test was used with a contingency table with a dichotomous trait (deterioration vs. no deterioration), with a 5-dB increase defined as a clinically significant deterioration. RESULTS Immediately after intratympanic injection of GBCA, no adverse reactions were observed. Otomicroscopic and tympanometric control of the tympanic membrane showed regular function on the day after injection. The perforation site was healed in all patients, and there was no sign of middle ear disease. At long-term evaluation, including otomicroscopy and tympanometry, no adverse reactions were observed. and the tympanic membrane had regular function. The average time of long-term evaluation after MRI is shown in Table I. All subjects had enhancement throughout the cochlea after intratympanic injection of GBCA. In five patients (29%) ELH was detected, and in 12 patients (71%) no ELH was detected on MRI according to previously reported criteria. 5 Patients without ELH had the following diagnoses: vestibular migraine (six patients), fluctuating hearing loss (three patients), initial stage of Menières disease without ELH (two patients), and vestibular paroxysmia (one patient). Injected Ear One day after application of GBCA and at the longterm evaluation, no statistical difference in airconduction PTA was found (P >.05; Figs. 1 and 2). Application of GBCA One day before MRI, GBCA was injected into the middle ear of each patient. The procedure was performed under microscopic control with a 27-gauge needle. The patient was lying in a supine position with the head turned 45 to the opposite side. After local anesthesia of the ear canal with 4% tetracaine, about 0.4 ml of GBCA (gadopentetate dimeglumine) diluted eightfold with saline solution was injected through the tympanic membrane. After injection, the patient remained in the supine position, without speaking and swallowing, for 30 minutes so that the injected solution was able to diffuse into the inner ear. Audiologic Evaluation Before and after injection, the tympanic membrane was checked by otomicroscopy and tympanometry. Audiological tests consisted of pure-tone audiometry by air conduction at the frequencies of 250 Hz to 8.0 khz. PTA was calculated at the frequencies 0.5, 1.0, 2.0, and 3.0 khz. 11 All audiometric equipment Fig. 1. Pure-tone average before and 1 day after gadoliniumbased contrast agent injection. 2367
3 Fig. 2. Pure-tone average before and long term after gadoliniumbased contrast agent injection. Table II shows the outcome in percentages at 1 day and at long-term evaluation according to the recommendation of outcome evaluation after otologic surgery. In most cases there was a small change in PTA. The individual frequencies were likewise analyzed at 1 day after injection and at long-term evaluation. No statistical difference from baseline was found (P >.05). For better illustration, the difference of the mean values for each frequency was calculated. Positive values indicate deterioration; negative values indicate improvement (Fig. 3). In 16 patients, no evidence of ototoxicity after longterm evaluation was found. One patient (60 years old, female) had a deterioration of 10 to 20 db in the frequencies 3 khz, 4 khz, 6 khz, and 8 khz. However, this deterioration was not related to the GBCA injection, as she had the same deterioration on the contralateral side. Noninjected Ear The results in long-term control were calculated as described above (Fig. 4). Similar to the injected side, there was a very small deterioration in the long-term control. However, this difference was not significant between injected and noninjected ears in McNemar s binominal distribution test (P 5 1.0). Fig. 3. Mean difference in hearing level at each frequency 1 day and long term after gadolinium-based contrast agent injection. For better illustration of the effect of GBCA alone without the physiological effect of aging, the mean values of the difference of the noninjected side were subtracted from those of the injected side. The results are shown in Figure 5. In all frequencies there was no significant deterioration. DISCUSSION The intratympanic application route of GBCA is being increasingly used in the diagnosis of Menières disease. MRI with GBCA is an important tool, not only for diagnosis, but also in the follow-up, 13 and to evaluate the therapeutic results. 14,15 Furthermore, important new insights into the transport mechanisms of substances across the middle ear can be gained, such as the middle ear - inner ear barrier can be obtained from imaging studies after intratympanic GBCA application. Recently, the oval window could be identified as a major transmission route, whereas traditionally, the round window was thought to be the main entry point into the inner ear. 16,17 Therefore, analysis of possible side effects concerning the cochlea and hearing function is important. Our results show no long-term ototoxicity after the intratympanic use of GBCA for MRI. These results TABLE II. Outcome in Percentage Change. Percentage Change db Better db Worse Mean SD < to to 0 1 to to to One day after Long term Air-conduction, four-tone pure-tone average 0.5, 1, 2, and 3 khz; negative values indicate better hearing. SD 5 standard deviation. 2368
4 Fig. 4. Mean difference in hearing level at each frequency at long term on noninjected ear. confirm the observations of previous studies analyzing hearing thresholds after GBCA, which showed no shortterm side effects or ototoxicity. 9,10 Animal studies from Tanaka et al. 18 showed morphological changes such as shape changing, hair cell impairment, and cell shrinkage in vestibular end organs of bullfrogs after application of fourfold diluted GBCA. With the eightfold and sixteenfold dilution, the morphological changes were less frequent. The mode of application in their study, however, differed markedly from the clinical situation, because the vestibular hair cells and the isolated vestibular organs were bathed directly in the diluted GBCA solution. During clinical application, however, diluted GBCA that is applied intratympanically only enters the inner ear in minute amounts, resulting in a further dilution by a factor of about On the other hand, a different animal study from Kakigi et al. 8 showed no effect of an eightfold dilution on the stria vascularis of guinea pigs. Regarding the distribution of GBCA in the inner ear after intratympanic injection, Yoshika et al. 20 showed that 18% of the injected ears had no or poor round window permeability for GBCA. In addition, they found that 2 hours after application of GBCA, the contrast was clearly visible in the scala vestibule on MRI. However, there were no comments about the possible adverse effects on hearing function after the intratympanic application. A similar study by Fukuoka et al. 21 showed that the distribution of GBCA in the perilymphatic space of the inner ear is variable. GBCA penetrates the inner ear through the round window membrane and reaches all perilymphatic spaces after 24 hours. The patterns of distribution differed individually and probably depended on the size of the endolymphatic space. Regarding hearing function, there was no deterioration of the PTA in all 26 examined ears. With this study, we investigated the possibility of long-term changes in hearing function after application of intratympanic GBCA. The results obtained showed no deterioration in PTA in 17 patients after an average of 19 months postinjection. The minimum observation time was 7 months and the maximum was 34 months. At long-term evaluation, none of the patients reported the subjective feeling of fluctuating hearing loss. The noninjected ear was also analyzed long term to eliminate confounding factors such as the effects of time, age, and an independent bilateral cochlear degeneration (e.g., presbycusis). In one patient, a detailed analysis was performed, as some deterioration appeared 30 months postinjection. She was 60 years old at the time of the MRI. An effect of GBCA could be excluded, as she had a symmetrical deterioration in the noninjected ear. In the higher frequencies only, a slight deterioration after long-term evaluation could be observed. This tendency is probably due to the normal ageing process, as both ears showed the same trend. Limitations of the study were the small study population and the absence of different age cohorts. Particularly for higher frequencies, pure-tone audiometry with frequencies more than 8,000 Hz are needed. CONCLUSION The application of intratympanic GBCA seems to be a safe method, particularly with regard to the hearing function. No long-term effects on hearing threshold could be found. Acknowledgments The authors are grateful to Professor Eva Grill, Department of Epidemiology and German Centre for Vertigo and Balance Disorders, for the discussion of statistical test applications. BIBLIOGRAPHY Fig. 5. Mean difference of the noninjected side subtracted from the injected side at each frequency. 1. Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Menières disease. Laryngoscope 2007; 117:
5 2. Pyykk o I, Zou J, Poe D, et al. Magnetic resonance imaging of the inner ear in Menière s disease. Otolaryngol Clin North Am 2010;15: G urkov R, Flatz W, Louza J, et al. In vivo visualized endolymphatic hydrops and inner ear functions in patients with electrocochleographically confirmed Menière s disease. Otol Neurotol 2012;33: Nakada T, Yoshida T, Suga K et al. Endolymphatic space size in patients with vestibular migraine and Menières disease. J Neurol 2014;261: G urkov R, Kantner C, Strupp M, et al. Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms. Eur Arch Otorhinolaryngol 2014;271: Hao D, Ai T, Goerner F, et al. MRI contrast agents: basic chemistry and safety. J Magn Reson Imaging 2012;36: Magnevist injection [package insert]. Wayne, NJ: Bayer HealthCare Pharmaceuticals Inc.; Kakigi A, Nishimura M, Takeda T, et al. Effects of gadolinium injected into the middle ear on the stria vascularis. Acta Otolaryngol 2008;128: Louza JP, Flatz W, Krause E, et al. Short-term audiologic effect of intratympanic gadolinium contrast agent application in patients with Menières disease. Am J Otolaryngol 2012;33: Louza J, Krause E, G urkov R. Audiologic evaluation of Menière s disease patients one day and one week after intratympanic application of gadolinium contrast agent: our experience in sixty-five patients. Clin Otolaryngol 2013;38: American Academy of Otolaryngology-Head and Neck Foundation, Inc. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menières disease. Otolaryngol Head and Neck Surg 1995;113: American Speech-Language-Hearing Association Audiologic management of individuals receiving cochleotoxic drug therapy [guidelines]. Available at: ASHA 2002 Desk Reference Volume Jerin C, Krause E, Ertl-Wagner B, et al. Longitudinal assessment of endolymphatic hydrops with contrast-enhanced magnetic resonance imaging of the labyrinth. Otol Neurotol 2014;35: G urkov R, Flatz W, Keeser D, et al. Effect of standard-dose Betahistine on endolymphatic hydrops: an MRI pilot study. Eur Arch Otorhinolaryngol 2013;270: G urkov R, Berman A, Dietrich O, et al. MR volumetric assessment of endolymphatic hydrops. Eur Radiol 2015;25: King EB, Salt AN, Eastwood HT, et al. Direct entry of gadolinium into the vestibule following intratympanic applications in Guinea pigs and the influence of cochlear implantation. J Assoc Res Otolaryngol 2011;12: Zou, J, Pyyk o I. Enhanced oval window and block round window passages for middle-inner ear transportation of gadolinium in guinea pigs with a perforated round window membrane. Eur Arch Otorhinolaryngol 2015; 272: Tanaka F, Tanigawa T, Suzuki M, et al. Effects of MRI contrast agents (Omniscan) on vestibular end organs. Acta Otolaryngol 2010;130: Naganawa S, Nakashima T. Visualization of endolymphatic hydrops with MR imaging in patients with Menières disease and related pathologies: current status of its methods and clinical significance. Jpn J Radiol 2014;32: Yoshika M, Naganawa S, Sone M, et al. Individual differences in the permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear. Otol Neurotol 2009;30: Fukuoka H, Tsukada K, Miyagawa M, et al. Semi-quantitative evaluation of endolymphatic hydrops by bilateral intratympanic gadolinium-based contrast agent (GBCA) administration with MRI for Menières disease. Acta Otolaryngol 2010;130:
Meniere s disease and Sudden Sensorineural Hearing Loss
Meniere s disease and Sudden Sensorineural Hearing Loss Tsutomu Nakashima 1,2 1 Ichinomiya Medical Treatment & Habilitation Center, Ichinomiya, Japan 2 Department of Otorhinolaryngology, Nagoya University,
More informationThe Relationship Between Endolymphatic Hydrops in the Vestibule and Low-Frequency Air-Bone Gaps
The Laryngoscope VC 2017 The American Laryngological, Rhinological and Otological Society, Inc. The Relationship Between Endolymphatic Hydrops in the Vestibule and Low-Frequency Air-Bone Gaps Satofumi
More informationHISAKUNI FUKUOKA 1, YUTAKA TAKUMI 1, KEITA TSUKADA 1, MAIKO MIYAGAWA 1, TOMOHIRO OGUCHI 1, HITOSHI UEDA 2, MASUMI KADOYA 2 & SHIN-ICHI USAMI 1
Acta Oto-Laryngologica, 2012; 132: 141 145 ORIGINAL ARTICLE Comparison of the diagnostic value of 3 T MRI after intratympanic injection of GBCA, electrocochleography, and the glycerol test in patients
More informationShinji Naganawa Tsutomu Nakashima. Introduction
Jpn J Radiol (2014) 32:191 204 DOI 10.1007/s11604-014-0290-4 REVIEW Visualization of endolymphatic hydrops with MR imaging in patients with Ménière s disease and related pathologies: current status of
More information15 Marzo 2014 Aspetti radiologici dei disordini vestibolari: approccio multidisciplinare
15 Marzo 2014 Aspetti radiologici dei disordini vestibolari: approccio multidisciplinare MR Imaging of inner ear endo-perilymphatic spaces at 3T after intratympanic contrast agent administration in Definite
More informationMRI Inner Ear Imaging and Tone Burst Electrocochleography in the Diagnosis of
Otology & Neurotology 36:1109Y1114 Ó 2015, Otology & Neurotology, Inc. MRI Inner Ear Imaging and Tone Burst Electrocochleography in the Diagnosis of Ménière s Disease * Jeremy Hornibrook, *Edward Flook,
More informationEndolymphatic hydrops in patients with vestibular migraine and auditory symptoms
DOI 10.1007/s00405-013-2751-2 OTOLOGY Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms Robert Gürkov Claudia Kantner Michael Strupp W. Flatz Eike Krause Birgit Ertl-Wagner
More informationIntratympanic Steroid Therapy in Moderate Sudden Hearing Loss: A Randomized, Triple-Blind, Placebo-Controlled Trial
The Laryngoscope VC 2013 The American Laryngological, Rhinological and Otological Society, Inc. Intratympanic Steroid Therapy in Moderate Sudden Hearing Loss: A Randomized, Triple-Blind, Placebo-Controlled
More informationClinically applicable objective diagnosis of Ménière's disease by MR: How "to do" it
Clinically applicable objective diagnosis of Ménière's disease by MR: How "to do" it Poster No.: C-0488 Congress: ECR 2013 Type: Authors: Keywords: DOI: Educational Exhibit S. Naganawa, M. Yamazaki, H.
More informationEffect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere s Disease
Original Article Iranian Journal of Otorhinolaryngology, Vol.26(3), Serial No.76, Jul 2014 Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere s Disease Abstract Faramarz
More informationClinical Characteristics of Labyrinthine Concussion
online ML Comm ORIGINAL ARTICLE Korean J Audiol 2013;17:13-17 pissn 2092-9862 / eissn 2093-3797 http://dx.doi.org/10.7874/kja.2013.17.1.13 Clinical Characteristics of Labyrinthine Concussion Mi Suk Choi,
More informationVisualization of Endolymphatic Hydrops after Intratympanic Injection of Gd-DTPA: Comparison of 2D and 3D Real Inversion Recovery Imaging
Magn Reson Med Sci, Vol. 10, No. 2, pp. 101 106, 2011 MAJOR PAPER Visualization of Endolymphatic Hydrops after Intratympanic Injection of Gd-DTPA: Comparison of 2D and 3D Real Inversion Recovery Imaging
More informationWhat is Meniere's disease? What causes Meniere's disease?
NIH Publication No 95-3403 November 1994 What is Meniere's disease? Meniere's disease is an abnormality of the inner ear causing a host of symptoms, including vertigo or severe dizziness, tinnitus or a
More informationClinical Characteristics and Short-term Outcomes of Acute Low Frequency Sensorineural Hearing Loss With Vertigo
Original Article Clinical and Experimental Otorhinolaryngology Vol. 11, No. 2: 96-101, June 2018 https://doi.org/10.21053/ceo.2017.00948 pissn 1976-8710 eissn 2005-0720 Clinical Characteristics and Short-term
More informationUniversity of Groningen. Definition Menière Groningen Mateijsen, Dionisius Jozef Maria
University of Groningen Definition Menière Groningen Mateijsen, Dionisius Jozef Maria IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationDelayed Endolymphatic Hydrops: Episodic Vertigo of Delayed Onset after Profound Inner Ear Hearing Loss
Delayed Endolymphatic Hydrops: Episodic Vertigo of Delayed Onset after Profound Inner Ear Hearing Loss Tamio Kamei 1, MD, PhD and Kenji Watanabe 2, MD 1 Professor emeritus at Gunma University, Japan 2
More informationMR imaging of endolymphatic hydrops in 10 minutes: A new strategy for dramatic scan time reduction
MR imaging of endolymphatic hydrops in 10 minutes: A new strategy for dramatic scan time reduction Poster No.: C-0020 Congress: ECR 2014 Type: Scientific Exhibit Authors: S. Naganawa, K. Bokura, H. Kawai,
More informationCochlear Implant Impedance Fluctuation in Ménière s Disease: A Case Study
Otology & Neurotology xx:xx xx ß 2016, Otology & Neurotology, Inc. Cochlear Implant Impedance Fluctuation in Ménière s Disease: A Case Study Celene McNeill and Kate Eykamp Healthy Hearing and Balance Care,
More informationKathmandu University Medical Journal (2009), Vol. 7, No. 4, Issue 28,
Kathmandu University Medical Journal (2009), Vol. 7, No. 4, Issue 28, 397-401 Original Article Observation of hearing loss in patients with chronic suppurative otitis media tubotympanic type Maharjan M
More informationMénière s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops
Open Access To cite: Pyykkö I, Nakashima T, Yoshida T, et al. Ménière s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops. BMJ Open 2013;3:e001555.
More informationIntratympanic Injections of a Pharmacologic Agent for the Treatment of Meniere s Disease or Sudden Hearing Loss. Original Policy Date
MP 2.01.47 Intratympanic Injections of a Pharmacologic Agent for the Treatment of Meniere s Disease or Sudden Hearing Loss Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last
More informationVestibular Schwannoma and Ipsilateral Endolymphatic Hydrops: An Unusual Association
CASE REPORT DOI: 10.5935/0946-5448.20170024 International Tinnitus Journal. 2017;21(2):128-132. Vestibular Schwannoma and Ipsilateral Endolymphatic Hydrops: An Unusual Association Massimo Ralli 1 Antonio
More informationDrug delivery to the inner ear
Intratympanic Drug Delivery Society of Otorhinolaryngology and Head-Neck Nurses Advantages of intratympanic delivery Higher concentration of drug at site of action Avoid systemic effects May be able to
More informationG. Doobe, 1 A. Ernst, 1 R. Ramalingam, 2 P. Mittmann, 1 and I. Todt Introduction. 2. Materials and Methods
BioMed Research International Volume 2015, Article ID 457318, 4 pages http://dx.doi.org/10.1155/2015/457318 Research Article Simultaneous Labyrinthectomy and Cochlear Implantation for Patients with Single-Sided
More informationALESSANDRA RUSSO MD GRUPPO OTOLOGICO
Gruppo Otologico Simultaneous Labyrinthectomy with Cochlear Implantation Cenacolo di Audiovestibologia, Chieti, 24-25/06/2016 ALESSANDRA RUSSO MD GRUPPO OTOLOGICO MENIERE DISEASE Therapeutic Steps 1 step
More informationTenotomy of the middle ear muscles causes a dramatic reduction in vertigo attacks and improves audiological function in definite Meniere s disease
Acta Oto-Laryngologica, ; Early Online, 7 ORIGINAL ARTICLE Tenotomy of the middle ear muscles causes a dramatic reduction in vertigo attacks and improves audiological function in definite Meniere s disease
More informationResponse Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere s Disease Patients
J Int Adv Otol 2016; 12(1): 95-100 DOI: 10.5152/iao.2016.2177 Original Article Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere s Disease Patients Nabil Atrache
More informationClinical outcomes with betahistine in vestibular disorders
Clinical outcomes with betahistine in vestibular disorders Michael Strupp MD, FRCP, FANA, FEAN Department of Neurology, German Center for Vertigo and Balance Disorders University of Munich Role of betahistine
More informationMÉNIÈRE S DISEASE (MD)
Progression of Symptoms of Dizziness in Ménière s Disease Mari Havia, MD; Erna Kentala, MD, PhD ORIGINAL ARTICLE Objective: To evaluate the progression of symptoms of dizziness in Ménière s disease (MD)
More informationA patient with endolymphatic hydrops may experience any combination of the below described symptoms:
MENIERE S DISEASE Endolymphatic hydrops and Meniere s disease are disorders of the inner ear. Although the cause is unknown, it probably results from an abnormality of the fluids of the inner ear. In most
More informationSudden sensorineural hearing loss (SSNHL) is defined
Transtympanic steroids for treatment of sudden hearing loss GERARD J. GIANOLI, MD, FACS, and JOHN C. LI, MD, FACS, Baton Rouge, Louisiana, and Jupiter, Florida OBJECTIVES: To determine whether transtympanic
More informationSpartan Medical Research Journal
Spartan Medical Research Journal Research at Michigan State University College of Osteopathic Medicine Volume 3 Number 2 Fall, 2018 Pages 113-122 Title: Correlation of Clinical Factors and Audiometric
More informationHearing Outcome of Low-tone Compared to High-tone Sudden Sensorineural Hearing Loss
THIEME Original Research Hearing Outcome of Low-tone Compared to High-tone Sudden Sensorineural Hearing Loss George Psillas 1 Aikaterini Rizou 1 Dimitrios Rachovitsas 1 Gabriel Tsiropoulos 1 Jiannis Constantinidis
More informationAudiology (Clinical Applications)
(Clinical Applications) Sasan Dabiri, M.D. Assistant Professor Department of Otorhinolaryngology Head & Neck Surgery Amir A lam hospital Tehran University of Medical Sciences Last Updated in February 2015
More informationEndolymphatic Duct Blockage for Refractory Ménière s Disease: Assessment of Endolymphatic Sac Biopsy on Short-Term Surgical Outcomes
J Int Adv Otol 2016; 12(3): 310-5 DOI: 10.5152/iao.2016.3069 Original Article Endolymphatic Duct Blockage for Refractory Ménière s Disease: Assessment of Endolymphatic Sac Biopsy on Short-Term Surgical
More informationClinical Experience in Diagnosis and Management of Superior Semicircular Canal Dehiscence in Children
The Laryngoscope VC 2011 The American Laryngological, Rhinological and Otological Society, Inc. Clinical Experience in Diagnosis and Management of Superior Semicircular Canal Dehiscence in Children Gi
More informationIntratympanic Steroid Treatment as a Primary Therapy in Idiopathic Sudden Sensorineural Hearing Loss
Int. Adv. Otol. 2009; 5:(3) 334-339 ORIGINAL ARTICLE Intratympanic Steroid Treatment as a Primary Therapy in Idiopathic Sudden Sensorineural Hearing Loss Ljiljana Cvorovic, Mile Strbac, Milan B. Jovanovic,
More informationMEASUREMENTS AND EQUIPMENT FOR AUDIOLOGICAL EVALUATIONS
MEASUREMENTS AND EQUIPMENT FOR AUDIOLOGICAL EVALUATIONS Audiometric results will be analysed according to the following guidelines indicated in literature. 1. Otoscopic Examination The different structures
More informationMonitoring of Caloric Response and Outcome in Patients With Benign Paroxysmal Positional Vertigo
Otology & Neurotology 28:798Y800 Ó 2007, Otology & Neurotology, Inc. Monitoring of Caloric Response and Outcome in Patients With Benign Paroxysmal Positional Vertigo *Maria I. Molina, *Jose A. López-Escámez,
More informationSasan Dabiri, MD, Assistant Professor
Sasan Dabiri, MD, Assistant Professor Department of Otorhinolaryngology Head & Neck Surgery Amir A lam hospital Tehran University of Medical Sciences October 2015 Outlines Anatomy of Vestibular System
More informationWhat is Menière s disease? A contemporary re-evaluation of endolymphatic hydrops
DOI 10.1007/s00415-015-7930-1 REVIEW What is Menière s disease? A contemporary re-evaluation of endolymphatic hydrops R. Gürkov 1 I. Pyykö 2 J. Zou 3 E. Kentala 4 Received: 19 July 2015 / Revised: 4 October
More informationIntratympanic therapy of inner ear disease
Intratympanic therapy of inner ear disease Jack J. Wazen, M.D.FACS. VP & Director of Research Silverstein Institute Ear Research Foundation Sudden Sensorineural Definition Hearing Loss Sudden SNHL is defined
More informationJ.P.S. Bakshi Manual of Ear, Nose and Throat
J.P.S. Bakshi Manual of Ear, Nose and Throat Reading excerpt Manual of Ear, Nose and Throat of J.P.S. Bakshi Publisher: B. Jain http://www.narayana-publishers.com/b5603 Copying excerpts is not permitted.
More informationThe Role of Preoperative, Intratympanic Glucocorticoids for Hearing Preservation in Cochlear Implantation: A Prospective Clinical Study
The Laryngoscope VC 2011 The American Laryngological, Rhinological and Otological Society, Inc. The Role of Preoperative, Intratympanic Glucocorticoids for Hearing Preservation in Cochlear Implantation:
More informationNonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part II: Validation study
ORIGINAL SILMAN, ARICK, ARTICLE EMMER Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part II: Validation study Shlomo Silman, PhD; Daniel S. Arick, MD, FACS;
More informationDiagnosing and Treating Adults with Hearing Loss
Diagnosing and Treating Adults with Hearing Loss Diana Callesano, Au.D., CCC-A Eric Nelson, Au.D., CCC-A Clinical Audiologists Department of Otolaryngology Head and Neck Surgery Hearing and Speech Services
More informationClinical Indicators Useful in Predicting Response to the Medical Management of Meniere s Disease
The Laryngoscope Lippincott Williams & Wilkins, Inc., Philadelphia 2000 The American Laryngological, Rhinological and Otological Society, Inc. Clinical Indicators Useful in Predicting Response to the Medical
More informationTympanogenic Labyrinthitis (Cochlear Deafness) due to chronic suppurative otitis media (CSOM)
Tympanogenic Labyrinthitis (Cochlear Deafness) due to chronic suppurative otitis media (CSOM) * Dr. Raad A AlObaydi (FICS MBChB) Background: It has been accepted that in patients with CSOM, conductive
More informationSPECIAL PAPER IN CELEBRATION OF PROF. YANG'S 50 YEARS CAREER IN MEDICINE
JOURNAL OF OTOLOGY SPECIAL PAPER IN CELEBRATION OF PROF. YANG'S 50 YEARS CAREER IN MEDICINE ADVANCES IN SURGICAL TREATMENT OF ACOUSTIC NEUROMA HAN Dongyi,CAI Chaochan Acoustic Neuroma (AN) arises from
More informationProgression of Endolymphatic Hydrops in Ménière s Disease as Evaluated by Magnetic Resonance Imaging
Otology & Neurotology 32:1152Y1157 Ó 2011, Otology & Neurotology, Inc. Progression of Endolymphatic Hydrops in Ménière s Disease as Evaluated by Magnetic Resonance Imaging *Francesco Fiorino, Francesca
More informationEffects of Hyperbaric Therapy on Function and Morphology of Guinea Pig Cochlea with Endolymphatic Hydrops
Otology & Neurotology 25:553 558 2004, Otology & Neurotology, Inc. Effects of Hyperbaric Therapy on Function and Morphology of Guinea Pig Cochlea with Endolymphatic Hydrops Fang-Lu Chi, Qin Liang, and
More informationHearing loss and fluctuating hearing levels in X-linked hypophosphataemic osteomalacia
The Journal of Laryngology & Otology (2009), 123, 136 140. # 2008 JLO (1984) Limited doi:10.1017/s0022215107001636 Clinical Record Hearing loss and fluctuating hearing levels in X-linked hypophosphataemic
More informationIntratympanic steroid injection as a salvage treatment for sudden sensorineural hearing loss
The Journal of Laryngology & Otology, 1 of 6. JLO (1984) Limited, 2014 doi:10.1017/s0022215114002710 MAIN ARTICLE Intratympanic steroid injection as a salvage treatment for sudden sensorineural hearing
More informationPublic Statement: Medical Policy Statement:
Medical Policy Title: Implantable Bone ARBenefits Approval: 09/28/2011 Conduction Hearing Aids Effective Date: 01/01/2012 Document: ARB0190 Revision Date: Code(s): 69714 Implantation, osseointegrated implant,
More informationUNILATERAL MENIERE S DISEASE; INTRA TYMPANIC INJECTION OF LOW DOSE GENTAMICIN IN THE TREATMENT
The Professional Medical Journal DOI: 10.17957/TPMJ/16.3129 ORIGINAL PROF-3129 UNILATERAL MENIERE S DISEASE; INTRA TYMPANIC INJECTION OF LOW DOSE GENTAMICIN IN THE TREATMENT 1. Professor and Consultant
More informationMigraine Features in Patients With Meniere s Disease
The Laryngoscope VC 2015 The American Laryngological, Rhinological and Otological Society, Inc. Migraine Features in Patients With Meniere s Disease Yaser Ghavami, MD; Hossein Mahboubi, MD, MPH; Amy Y.
More informationHigh-Frequency Sensorineural Hearing Loss in Children
The Laryngoscope VC 2015 The American Laryngological, Rhinological and Otological Society, Inc. High-Frequency Sensorineural Hearing Loss in Children Kaalan Johnson, MD; Meredith Tabangin, MPH; Jareen
More informationLong-Term Follow-Up of Tinnitus in Patients with Otosclerosis After Stapes Surgery
International Tinnitus Journal, Vol. 10, No.2, 197-201 (2004) Long-Term Follow-Up of Tinnitus in Patients with Otosclerosis After Stapes Surgery Pollyanna G. Sobrinho, Carlos A. Oliveira, and Alessandra
More informationPage: 1 of 6. Transtympanic Micropressure Applications as a Treatment of Meniere's Disease
Page: 1 of 6 Last Review Status/Date: December 2013 as a Treatment of Meniere's Disease Description Transtympanic micropressure treatment for Meniere s disease involves use of a hand-held air pressure
More informationAssisting in Otolaryngology
Assisting in Otolaryngology Learning Objectives Identify the structures and explain the functions of the external, middle, and internal ear. Describe the conditions that can lead to hearing loss, including
More informationIntratympanic Gentamicin Therapy for Vertigo in Nonserviceable Ears
Intratympanic Gentamicin Therapy for Vertigo in Nonserviceable Ears Paul W. Bauer, MD, C. Bruce MacDonald, MD, and L. Clarke Cox, PhD Purpose: Intratympanic ototoxic agents have become a widely accepted
More informationTranstympanic Micropressure Applications as a Treatment of Meniere s Disease
Transtympanic Micropressure Applications as a Treatment of Meniere s Disease Policy Number: 1.01.23 Last Review: 8/2014 Origination: 2/2006 Next Review: 8/2015 Policy Blue Cross and Blue Shield of Kansas
More informationSudden Sensorineural Hearing Loss; Prognostic Factors
Original Article Iranian Journal of Otorhinolaryngology, Vol.27(5), Serial No.82, Sep 2015 Abstract Sudden Sensorineural Hearing Loss; Prognostic Factors Dass Arjun 1, * Goel Neha 1, Singhal Surinder K
More informationCITY & HACKNEY PATHFINDER CLINICAL COMMISSIONING GROUP. Vertigo. (1) Vertigo. (4) Provisional Diagnosis. (5) Investigations. lasting days or weeks
Authors: Dr Lucy O'Rouke and Mr N Eynon-Lewis Review date: January 2017 Vertigo (1) Vertigo (2) History (3) Examination (4) Provisional Diagnosis (5) Investigations (6) Medical Cause (7) Psychiatric Cause
More informationComparison - Effectiveness of oral steroid versus intratympanic Dexamethasone for sudden onset sensorineural hearing loss.
Volume : 5; Issue1; pp 7-13 Comparison - Effectiveness of oral steroid versus intratympanic Dexamethasone for sudden onset sensorineural hearing loss. Rupasinghe R.A.S.T. National Hospital of Sri Lanka.
More informationAcquired Deafness Loss of hearing that occurs or develops sometime in the course of a lifetime, but is not present at birth.
Page 1 of 5 URMC» Audiology Glossary of Terms A Acoustic Neuroma A tumor, usually benign, which develops on the hearing and balance nerves and can cause gradual hearing loss, tinnitus, and dizziness. Acquired
More informationIntratympanic Therapies for Menière s Disease
Curr Otorhinolaryngol Rep (2014) 2:137 143 DOI 10.1007/s40136-014-0055-8 MENIERE S DISEASE (L LUSTIG, SECTION EDITOR) Intratympanic Therapies for Menière s Disease Matthew W. Miller Yuri Agrawal Published
More informationSuperior Semicircular Canal Dehiscence Mimicking Otosclerotic Hearing Loss
Arnold W, Häusler R (eds): Otosclerosis and Stapes Surgery. Adv Otorhinolaryngol. Basel, Karger, 7, vol 65, pp 137 145 Superior Semicircular Canal Dehiscence Mimicking Otosclerotic Hearing Loss Saumil
More informationHEARING IMPAIRMENT LEARNING OBJECTIVES: Divisions of the Ear. Inner Ear. The inner ear consists of: Cochlea Vestibular
HEARING IMPAIRMENT LEARNING OBJECTIVES: STUDENTS SHOULD BE ABLE TO: Recognize the clinical manifestation and to be able to request appropriate investigations Interpret lab investigations for basic management.
More informationSudden sensorineural hearing loss (SSNHL) was
Main Article Intratympanic Methylprednisolone Injection as First Line Therapy for Idiopathic Sudden Sensorineural Hearing Loss Mukul Patar, 1 Rupanjita Sangma 1 ABSTRACT Introduction Steroid therapy is
More informationSubject: Implantable Bone-Conduction and Bone- Anchored Hearing Aids
02-69000-06 Original Effective Date: 08/15/03 Reviewed: 09/27/18 Revised: 10/15/18 Subject: Implantable Bone-Conduction and Bone- Anchored Hearing Aids THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION,
More informationAccording to the 1985 American Academy of Otolaryngology- Detection and Grading of Endolymphatic Hydrops in Menière Disease Using MR Imaging
ORIGINAL RESEARCH HEAD & NECK Detection and Grading of Endolymphatic Hydrops in Menière Disease Using MR Imaging K. Baráth, B. Schuknecht, A. Monge Naldi, T. Schrepfer, C.J. Bockisch, and S.C.A. Hegemann
More informationIntratympanic application of gentamicin for treatment of
Keio Journal of Medicine 35: 36-41, 1986 Lecture Intratympanic application of gentamicin for treatment of Meniere's disease Chlodwig Beck Department of Otolaryngology, Freiburg University Killianstr. 5.
More informationGUIDANCE. Evidence for the use of grommets as a surgical intervention in otitis media with effusion.
Bedfordshire and Hertfordshire Priorities Forum Statement Number: 72 Subject: Grommet insertion in adults Date of decision: January 2017 Date of review: January 2020 GUIDANCE Criteria for the funding of
More informationAssessing the Deaf & the Dizzy. Phil Bird Senior Lecturer University of Otago, Christchurch Consultant Otolaryngologist CPH & Private
Assessing the Deaf & the Dizzy Phil Bird Senior Lecturer University of Otago, Christchurch Consultant Otolaryngologist CPH & Private Overview Severe & profoundly deaf children & adults Neonatal screening
More informationMEDICAL POLICY SUBJECT: COCHLEAR IMPLANTS AND AUDITORY BRAINSTEM IMPLANTS
MEDICAL POLICY. PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationManagement of Ear, Hearing and Balance Disorders: Fact, Fiction, and Future
Management of Ear, Hearing and Balance Disorders: Fact, Fiction, and Future George W. Hicks, M,D. 7440 N. Shadeland Avenue, Suite 150 Indianapolis, IN 46250 904 N. Samuel Moore Parkway Mooresville, IN
More informationManagement of Idiopathic Sudden Sensorineural Hearing Loss: Experience in Newly Developing Qatar
International Tinnitus Journal, Vol. 10, No.2, 165-169 (2004) Management of Idiopathic Sudden Sensorineural Hearing Loss: Experience in Newly Developing Qatar Ahmed Harith Salahaldin,l Abdulbari Bener,2
More informationHearing loss following temporal bone fractures- a study on classification of fractures and the prognosis
International Journal of Otorhinolaryngology and Head and Neck Surgery Maradi N et al. Int J Otorhinolaryngol Head Neck Surg. 2017 Apr;3(2):390-394 http://www.ijorl.com pissn 2454-5929 eissn 2454-5937
More informationCochlear Implant, Bone Anchored Hearing Aids, and Auditory Brainstem Implant
Origination: 06/23/08 Revised: 10/15/16 Annual Review: 11/10/16 Purpose: To provide cochlear implant, bone anchored hearing aids, and auditory brainstem implant guidelines for the Medical Department staff
More informationHearing Loss: From Audiogram to RFC Learn How to Effectively Represent Deaf and Hard of Hearing Claimants
V Hearing Loss: From Audiogram to RFC Learn How to Effectively Represent Deaf and Hard of Hearing Claimants Michael Liner, Esq. Mark Mehle, MD Andrew November, Esq. Hearing Loss: From Audiogram to RFC
More informationSystematic review of ototoxic pre-surgical antiseptic preparations what is the evidence?
Singh and Blakley Journal of Otolaryngology - Head and Neck Surgery (2018) 47:18 https://doi.org/10.1186/s40463-018-0265-z REVIEW Open Access Systematic review of ototoxic pre-surgical antiseptic preparations
More informationDraft Guidelines for the Onward Referral of Adults with Hearing Loss Directly Referred to Audiology Services (2016)
Draft Guidelines for the Onward Referral of Adults with Hearing Loss Directly Referred to Audiology Services (2016) Produced by: Service Quality Committee of the British Academy of Audiology Key Authors:
More informationORIGINAL ARTICLE. Comparison of hearing recovery criteria in sudden sensorineural hearing loss
Braz J Otorhinolaryngol. 2012;78(3):42-8. ORIGINAL ARTICLE BJORL Comparison of hearing recovery criteria in sudden sensorineural hearing loss Daniel Paganini Inoue 1, Eduardo Amaro Bogaz 2, Flávia Barros
More informationHearing fluctuation is not a predictor of vertigo attacks in Meniere s syndrome
52 Celene Mc Neill MA 1,2 William Gibson MD 3,4 Alan Taylor PhD 2 Hearing fluctuation is not a predictor of vertigo attacks in Meniere s syndrome Abstract 1 Healthy Hearing & Balnace Care, Sydney, Australia.
More informationincident series Bomb blast injuries to the ear: The London Bridge t g- SUMMARY INTRODUCTION 12,
Journal of Accident and Emergency Medicine 1995 12,194-198 Bomb blast injuries to the ear: The London Bridge incident series R.M. WALSH,1 J.P. PRACY,1 A.M. HUGGON2 & M.J. GLEESON' 'Department of Otolaryngology
More informationSurgical and Non-Surgical Causes of Progressive Hearing Loss in Children: What can be done about it?
Surgical and Non-Surgical Causes of Progressive Hearing Loss in Children: What can be done about it? Daniela Carvalho, MD, MMM, FAAP Professor, Surgery Department UCSD Pediatric Otolaryngology Rady Children
More informationTranstympanic Micropressure Applications as a Treatment of Meniere s Disease
Transtympanic Micropressure Applications as a Treatment of Meniere s Disease Policy Number: 1.01.23 Last Review: 8/2017 Origination: 2/2006 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas
More informationMénière s Society. Do you suffer from dizziness and imbalance as a result of a vestibular disorder?
Survey 2015 Ménière s Society The Rookery, Surrey Hills Business Park, Wotton, Surrey RH5 6QT. UK. +44 (0)1306 876883 info@menieres.org.uk www.menieres.org.uk Registered Charity No. 297246 Do you suffer
More informationResidual Hearing Preservation After Cochlear Implantation via Round Window or Cochleostomy Approach
The Laryngoscope VC 2014 The American Laryngological, Rhinological and Otological Society, Inc. Residual Hearing reservation After Cochlear Implantation via Round Window or Cochleostomy Approach Chuan-Hung
More informationChapter 13 Physics of the Ear and Hearing
Hearing 100 times greater dynamic range than vision Wide frequency range (20 ~ 20,000 Hz) Sense of hearing Mechanical system that stimulates the hair cells in the cochlea Sensors that produce action potentials
More informationPRESBYACUSIS A REVIEW
From the SelectedWorks of Balasubramanian Thiagarajan March 24, 2014 PRESBYACUSIS A REVIEW Balasubramanian Thiagarajan Available at: https://works.bepress.com/drtbalu/82/ Presbyacusis A Review Balasubramanian
More informationDifficult Cases: Controversies in Cochlear Implantation
Difficult Cases: Controversies in Cochlear Implantation David S Haynes, MD FACS Fred F Telischi, MD MEE FACS Lawrence R. Lustig, MD Robert F Labadie, PhD MD Nikolas H Blevins, MD Matthew L. Carlson, MD
More informationImaging Profile of the Ear in Hearing Loss Patients in Hospital Universiti Sains Malaysia: 5 year Cross Sectional Analysis at a Tertiary
Imaging Profile of the Ear in Hearing Loss Patients in Hospital Universiti Sains Malaysia: 5 year Cross Sectional Analysis at a Tertiary Otologic Centre Rohaizam bin Japar 1, Dinsuhaimi bin Sidek 1, Suzina
More informationEFFICACY AND SAFETY OF INTRATYMPANIC STEROID TREATMENT FOR IDIOPATHIC SUDDEN SENSORINEURAL HEARING LOSS
Original research article International Journal of Medical Science and Education pissn- 2348 4438 eissn-2349-3208 EFFICACY AND SAFETY OF INTRATYMPANIC STEROID TREATMENT FOR IDIOPATHIC SUDDEN SENSORINEURAL
More informationphoto courtesy of Oticon Glossary
photo courtesy of Oticon Glossary 404.591.1884 www.childrensent.com American Sign Language (ASL): a manual language with its own word order and grammar, used primarily by people who are Deaf. Atresia (aural):
More informationAir conduction hearing thresholds of young and older Japanese adults for pure tones from 125 Hz to 16 khz
TECHNICAL REPORT #2011 The Acoustical Society of Japan Air conduction hearing thresholds of young and older Japanese adults for pure tones from 125 Hz to 16 khz Kenji Kurakata 1;, Tazu Mizunami 1, Kazuma
More informationWV OTORHINOLARYNGOLOGY. EAR, NOSE AND THROAT MEDICINE
WV OTORHINOLARYNGOLOGY. EAR, NOSE AND THROAT MEDICINE 1 Societies 11 History 13 Dictionaries. Encyclopaedias. Bibliographies Use for general works only. Classify with specific aspect where possible 15
More informationThe close anatomic relationship between the cochlea and
ORIGINAL RESEARCH R.J. Young D.R. Shatzkes J.S. Babb A.K. Lalwani The Cochlear-Carotid Interval: Anatomic Variation and Potential Clinical Implications BACKGROUND AND PURPOSE: A temporal bone CT study
More information